Funding will directly accelerate our global drug mapping database, ranking 22,000 therapeutics against all human diseases.
Press Release
•
Every Cure Receives $15M NIH Grant
More from our News
Keep Reading
Press Release • Oct 13
The New Yorker Profiled Our Work!
When David Fajgenbaum was a twenty-five-year-old medical student, at the University of Pennsylvania, he started to feel so tired that he could barely stand.
Press Release • Oct 13
Every Cure named Overall Winner of Newsweek’s AI Impact Awards
Every Cure, a nonprofit working to reveal the untapped potential of existing medications, has emerged as the overall winner of Newsweek’s inaugural AI Impact Awards.
Press Release • Jul 21
Updated NCCN Guidelines Elevate Repurposed Treatment to Preferred Option for Patients with Rosai-Dorfman Disease
Lenalidomide/dexamethasone (len/dex) is now recommended as a preferred treatment option for patients with Rosai-Dorfman Disease regardless of mutation status, potentially expanding access to an effective,